Powerful Distribution Network

Broad Availability

Our products will be stocked in over 40 warehouses and thousands of pharmacies, cosmetic stores, and tobacconists.

Extensive Reach

SZ Pharmaceutical boasts a wide-reaching distribution network across the European Union.

Market Penetration

This extensive reach provides access to 90% of the relevant market in the country, ensuring wide audience engagement.

Beyond physical distribution, we leverage exhibitions, influencer marketing, and digital advertising to effectively promote our products.

Multifaceted Promotion

NEW PHARMACEUTICAL FORMULATIONS & EMA APPROVAL

Exploring psychedelic compounds for mental health solutions and breakthroughs.

New Formulations

SZ Pharmaceutical will register new pharmaceutical formulations upon final European Medicines Agency (EMA) approval, creating diversified revenue streams.

EMA Approval

Regulatory approval from the EMA signifies quality and safety, paving the way for market entry and revenue generation.

→

Market Impact

The registration of "Novel Food" products is projected to yield a valuation of €800M to €1B. Our robust distribution network (40+ warehouses and thousands of retail outlets) reaches 90% of the EU market, ensuring significant audience engagement.

The Future of Wellness

Groundbreaking Compounds

SZ Pharmaceutical focuses on developing novel therapies for overall health conditions using natural cannabinoids, breakthrough compounds for innovative mental health treatments and other groundbreaking compounds. These substances have shown promising results in treating a range of conditions, including pain, cancer, depression, anxiety, and PTSD.

Rigorous Clinical Trials

The company is committed to conducting rigorous clinical trials to ensure the safety and efficacy of its treatments. These trials are designed to evaluate the effectiveness of natural cannabinoids and breakthrough compounds for innovative mental health treatments and other innovative therapies in a controlled setting, providing evidence-based data to support their use.

Building on a Legacy of Innovation

Euro Pacific Hellas Heritage

Established in Greece, Euro Pacific Hellas has a long history of success in the pharmaceutical industry, known for its high-quality production and distribution of medicines.

Future-Focused Innovation

Strategic Acquisition

Building on this legacy, SZ Pharmaceutical acquired Euro Pacific Hellas, leveraging its expertise and infrastructure to develop innovative health care treatments.

SZ Pharmaceutical focuses on developing groundbreaking therapies using natural cannabinoids, breakthrough compounds for innovative mental health treatments and other novel compounds, aiming to revolutionize the treatment of health care conditions.

A Global Network of Expertise

Leading Universities

Strategic Collaboration Set to Revolutionize Medicinal Cannabis Research

SZ Pharmaceutical is proud to announce a groundbreaking partnership with three esteemed Greek institutions: the Medical School of the University of Athens, Aristotle University of Thessaloniki, and the University of Patras. This collaboration aims to pioneer the development of innovative medicinal cannabis products, transforming the pharmaceutical landscape.

A New Era in Medicinal Cannabis Development

By joining forces with these renowned universities, SZ Pharmaceutical seeks to address critical healthcare needs and improve patient outcomes. This partnership will explore various therapeutic applications, including Psychiatry, Oncology, and Pain Management. With a focus on rigorous scientific standards and ethical considerations, SZ Pharmaceutical is committed to prioritizing patient safety and efficacy.

Driving Innovation and Excellence

This cooperation marks a significant milestone in SZ Pharmaceutical's mission to harness the potential of medicinal cannabis for therapeutic use. By leveraging the expertise and resources of these academic partners, SZ Pharmaceutical aims to redefine the possibilities in medicinal cannabis and deliver hope to those in need. Stay tuned for further updates on this transformative journey.

World-Class Researchers

The company collaborates with renowned researchers, such as Dr. Ezekiel Golan, who brings deep knowledge and experience in the field of mental health and breakthrough compounds for innovative mental health treatments. Calvin Frye, a scientist and pioneer in the cannabis industry, also chairs a committee with the National Hemp Association.

International Partnerships

SZ Pharmaceutical seeks to expand its reach and impact through strategic partnerships with global institutions and organizations, fostering collaboration and knowledge exchange in the field of health care research.

A Comprehensive Approach to Overall Health

Cannabis-Based Products

The company holds a fully approved medical and recreational cannabis license, enabling the cultivation, production, and distribution of low and high THC products, expanding its portfolio to address a broader spectrum of patient needs.

Therapeutic Psychedelics

SZ Pharmaceutical focuses on developing therapeutic applications for breakthrough compounds for innovative mental health treatments, utilizing their potential to address a wide range of mental health conditions, including depression, anxiety, and PTSD.

Holistic Treatment

SZ Pharmaceutical believes in a holistic approach to wellness, integrating innovative therapies with traditional treatments and support services to provide comprehensive care for individuals seeking mental well-being.

Building a Better Future for Health Care

Accessibility

SZ Pharmaceutical strives to make its treatments accessible to a wider population, ensuring affordability and ease of access to innovative therapies for those seeking health care support.

Education and Awareness

The company is committed to raising awareness about health and the potential of natural cannabinoids and breakthrough compounds for innovative mental health therapies, promoting open conversations and reducing stigma associated with these treatments.

Empowerment

SZ Pharmaceutical aims to empower individuals to take control of their mental health journey, providing access to evidence-based treatments and resources to support their well-being and recovery.

SZ Pharmaceutical: A Vision for a Wellness Tomorrow

SZ Pharmaceutical is a new pharmaceutical company with a clear vision: to revolutionize overall health treatment by developing innovative therapies that leverage the potential of natural cannabinoids, breakthrough compounds for mental health treatments, and other groundbreaking compounds.

The company has secured production and distribution rights for several pioneering medicines pending clinical trials, demonstrating its commitment to bringing these treatments to market and making a tangible difference in the lives of those struggling with health conditions.

By collaborating with leading universities and researchers, SZ Pharmaceutical is committed to advancing the field of health care research and developing effective therapies that address the growing need for innovative treatment options.

Explore our products

Provide a short description of categories listed below.

EU Distribution Network

SZ Pharmaceutical products are widely available through a robust network of partners, encompassing pharmacies, cosmetic stores, and tobacconists.

• 40 Warehouses

• 10,000-12,000 Pharmacies

• 2,000-4,000 Cosmetics Stores

• 20,000 Tobacconists

Marketing and Promotion

A comprehensive marketing strategy ensures broad reach and awareness across diverse channels.

• Digital Advertising

• Influencer Marketing

• Doctor Network

• Product Promotion

• Exhibitions and Trade Shows

Targeted Reach

The marketing strategy ensures access to a significant proportion of the target audience.

Direct access to 90% of relevant publications and a strong presence at industry events ensures maximum visibility and impact.

SALES OF RAW MATERIALS AND MANUFACTURING SERVICES

Pharmaceutical Market

SZ Pharmaceutical will supply raw materials and finished products to a large market.

• Pharmacies

• Pharmaceutical Companies

• Medical Institutions

• Retailers

Healthcare Market

SZ Pharmaceutical will provide products to address a critical need in the Greek healthcare system.

There are 120,000 patients currently waiting for high-THC medicines.

Market Growth

The European and UK markets are projected to grow rapidly.

This represents a significant growth opportunity for SZ Pharmaceutical.

Subscribe to our newsletter

Enjoy exclusive special deals available only to our subscribers.

Join Our Journey

SZ Pharmaceutical invites investors, potential partners, and individuals passionate about healthcare innovation to join us on our journey to revolutionize healthcare. Together, we can create a healthier tomorrow.

SZ Pharmaceutical is committed to transparency and open communication with our investors. We regularly provide updates on our progress and financial performance.
For more information get in touch with us at:- info@szpharmaceutical.com

Contact Us

Reach out for inquiries about our innovative mental health treatments.